Sbir phase II - topic 225 - a system to coordinate and track home based chronic care in patients with cancer
Ended Definitive Contract Awarded Last action
- Contract number
- HHSN261200800033C
- Awardee
-
Dimagi Inc. UEI FY2NCML2TTW7
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $867,689
Award facts
- Opportunity
-
- N44PC8500118 Solicitation number
- Contract value 100% obligated
- $867,688.86 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources · 1 offer Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Charlestown, MA 02129, USA
- Research
- SBIR Program Phase II Action
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | -$330 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $868,019 |
About this award
This is a $867,688.86 federal contract awarded by the National Cancer Institute (NCI) to Dimagi Inc., a global social enterprise that develops digital health solutions and data collection software. The contract is a Small Business Innovation Research (SBIR) Phase II award for the development of a system to coordinate and track home-based chronic care for cancer patients.
Dimagi, a self-certified small disadvantaged business, is the prime contractor on this cost-plus-fixed-fee definitive contract. The contract has a period of performance through July 31, 2012 and was awarded on September 30, 2008 as a total small business set-aside. Dimagi's work under this contract aligns with the NCI's broader cancer research and treatment priorities, including its Cancer Moonshot program focused on improving cancer survivorship.
Quick answers
Who was awarded contract HHSN261200800033C?
HHSN261200800033C was awarded to Dimagi Inc. by National Cancer Institute (National Institutes of Health) on September 30, 2008.
How much is contract HHSN261200800033C worth?
The government has obligated $867,689 on HHSN261200800033C.
Was contract HHSN261200800033C competed?
The extent of competition for HHSN261200800033C was full and open competition after exclusion of sources. The government received 1 offer. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award